Tuesday, 17 November 2026

Is your compounding pharmacy in the right lane?

 
 
Is your compounding pharmacy in the right lane?
Two federal lanes, an ended GLP-1 shortage, new peptide policy, and a free checklist.
You want to give patients the hormone, weight-loss, and peptide options they ask about, and you want to do it the right way.
 
The problem is that the ground keeps shifting.
 
Under federal law, a 503A pharmacy compounds for an identified patient on a valid prescription and generally cannot supply office stock. A 503B outsourcing facility can. [1] FDA has declared both GLP-1 shortages resolved, so a pharmacy that regularly compounds copies of semaglutide or tirzepatide generally needs a prescriber-documented clinical difference for that patient. [2][3] Peptide policy is still moving. An October 28, 2026 HHS interim policy covers six peptides, but none has been added to the 503A bulks list. [4] fda clarifies policies compounders national glp 1 supply begins stabilize+2
 
You should not need a law degree to choose a pharmacy.
We wrote Research Brief No. 52 to help. It is independent, educational, and built for membership practices. The plan is simple:
  1. Know your lane. 503A for patient-specific prescriptions, 503B for office stock. [1]
  2. Get it in writing. Licensure, certificates, test data, and an adverse event process before the first order, rechecked annually. [5]
  3. Tell patients plainly. Compounded means not FDA-approved. Explain why you chose it. [5]
What is at stake: The brief cautions against building a practice on a single regulatory window. [5]
 
What you gain: A five-part diligence checklist your team can use this week. [5]
 
 
Sources
  1. U.S. Food and Drug Administration. Prescription Requirement Under Section 503A of the Federal Food, Drug, and Cosmetic Act, Guidance for Industry. https://fda.gov/media/97347/download
  2. U.S. Food and Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize. Updated April 1, 2026. https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize
  3. McDermott Will & Schulte. Tirzepatide Shortage Resolved. October 9, 2024, updated. https://www.mcdermottlaw.com/?p=290932
  4. Holland & Knight. HHS Issues Interim Enforcement Discretion Policy for Compounding of 6 Peptides. November 2026. https://www.hklaw.com/en/insights/publications/2026/11/hhs-issues-interim-enforcement-discretion-policy-for-compounding
  5. Concierge Medicine Today. Research Brief No. 52. October 2026. https://conciergemedicinetoday.net/compounding-pharmacy-diligence
Educational only. Not medical, legal, tax, financial, or accounting advice. Rules vary by state and change often. Consult a healthcare attorney and a pharmacist familiar with your states.
 
Visit our Facebook
Visit our Instagram
Visit our LinkedIn
Visit our Podcast
Visit our Website
Visit our Youtube
4080 McGinnis Ferry Road, Bldg 800, Ste 801
Alpharetta, GA 30005, USA
 

Latest from Food Politics: Why soda taxes matter: the Santa Cruz case history

Let’s start with some history. 2018: The American Beverage Association induced California to ban local taxes on sugar-sweetened beverages until 2030. 2023: A state appeals court said part of that law was unconstitutional,   2024: Voters in the ...
‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

By Marion Nestle

Why soda taxes matter: the Santa Cruz case history

Let’s start with some history.

The Santa Cruz soda tax has been the subject of a two-part investigation by Jesse Kathan and Elena DeBre:

These reports document the legal tactics used by the beverage industry to defeat public health measures.  Sometimes David wins against Goliath.  Santa Cruz is one of those instances.

The post Why soda taxes matter: the Santa Cruz case history appeared first on Food Politics by Marion Nestle

Now Available: What to Eat Now

My new book, What to Eat Now, is officially out!

It's both a field guide to food shopping in America and a reflection on how to eat well—and deliciously.

For more information and to order, click here.

You can explore the full archive of this (almost) daily blog at foodpolitics.com, where you'll also find information about my books, articles, media interviews, upcoming lectures, favorite resources, and FAQs.


​​​​​​​

Marion Nestle

Paulette Goddard Professor of Nutrition, Food Studies, and Public Health at New York University, Emerita


© Marion Nestle. You're receiving this email because you've signed up to receive updates from us.

If you'd prefer not to receive updates, you can unsubscribe.


More Nov Jobs in Concierge Medicine Posted

Your patients will never love your practice more than your team does.

Is your compounding pharmacy in the right lane?

A research brief on federal rules, plus a free diligence checklist  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ...